Powered by

Ultragenyx to Present at Upcoming Investor Conferences

Aug 30, 2019 - GlobeNewswire
Event Announcements

NOVATO, Calif., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, today announced that Shalini Sharp, the company's Chief Financial Officer, will present at the following conferences:

Baird Global Healthcare Conference on Thursday, September 5, 2019 at 12:50pm ET in New York, NY Morgan Stanley 17th Annual Global Healthcare Conference o...